Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

The Food and Drug Administration on Thursday formally approved Juul to sell its vape devices and nicotine pods. Dr. Robert ...

Johnson & Johnson (J&J) has halved its expectations for costs this year related to new tariffs and raised its full-year sales ...

Novartis (NVS) raised its full-year profit outlook thanks to strong demand for some of its key drugs. Novartis CEO Vas ...

American consumers of Korean cosmetics and skin-care products are bulk buying, as President Trump threatens 25 percent ...

Consumers picked up their spending in June showing resilience despite anxiety high over tariffs and the U.S. economy.

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Oil prices rose $1 on Thursday after drones struck Iraqi Kurdistan oil fields for a fourth day, pointing to continued risk in ...

Rather than continuing to retaliate with tariffs of its own, the Canadian government has begun to confess that such a tactic ...